Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Revenue	$ 81,411		$ 130,934
Cost of revenue	40,161		61,493
Gross profit	41,250		69,441
Expenses
Research and development, net	959,672	1,805,747	2,014,226	3,760,318
General and administrative	3,702,113	1,531,065	6,674,473	4,895,715
Sales and marketing	185,776	201,509	538,321	774,481
Transaction costs	203,000		5,620,436
Depreciation	61,090	74,791	175,902	229,643
Impairment	14,119,955		14,119,955
Foreign currency transaction (gain)/loss	115,476	(137,337)	(119,103)	(176,575)
Total expenses	19,347,082	3,475,775	29,024,210	9,483,582
Loss from operations	(19,305,832)	(3,475,775)	(28,954,769)	(9,483,582)
Other income / (expenses)
Changes in fair value of financial liabilities		(8,200,745)	34,333,573	(12,939,830)
Loss on debt settlement		(720,320)		(720,320)
Finance expense	(5,857,606)	(700,093)	(7,733,314)	(2,461,252)
Total Other income / (expenses)	(5,857,606)	(9,621,158)	26,600,259	(16,121,402)
Loss before taxes	(25,163,438)	(13,096,933)	(2,354,510)	(25,604,984)
Current income tax recovery			5
Net income (loss)	(25,163,438)	(13,096,933)	(2,354,505)	(25,604,984)
COMPREHENSIVE LOSS
Net income (loss)	(25,163,438)	(13,096,933)	(2,354,505)	(25,604,984)
Other comprehensive loss
Foreign currency translation adjustments	(3,307)		(2,248)
Comprehensive loss	$ (25,166,745)	$ (13,096,933)	$ (2,356,753)	$ (25,604,984)
Loss per share – basic (in Dollars per share)	$ (0.5)	$ (1.06)	$ (0.11)	$ (2.11)
Loss per share – diluted (in Dollars per share)	$ (0.5)	$ (1.06)	$ (0.11)	$ (2.11)
Weighted average number of shares outstanding – basic (in Shares)	50,566,406	12,303,733	21,855,268	12,135,890
Weighted average number of shares outstanding – diluted (in Shares)	50,566,406	12,303,733	21,855,268	12,135,890